346 related articles for article (PubMed ID: 31601650)
1. ERAP1 enzyme-mediated trimming and structural analyses of MHC I-bound precursor peptides yield novel insights into antigen processing and presentation.
Li L; Batliwala M; Bouvier M
J Biol Chem; 2019 Dec; 294(49):18534-18544. PubMed ID: 31601650
[TBL] [Abstract][Full Text] [Related]
2. ERAP1-ERAP2 dimers trim MHC I-bound precursor peptides; implications for understanding peptide editing.
Chen H; Li L; Weimershaus M; Evnouchidou I; van Endert P; Bouvier M
Sci Rep; 2016 Aug; 6():28902. PubMed ID: 27514473
[TBL] [Abstract][Full Text] [Related]
3. The partial dissociation of MHC class I-bound peptides exposes their N terminus to trimming by endoplasmic reticulum aminopeptidase 1.
Papakyriakou A; Reeves E; Beton M; Mikolajek H; Douglas L; Cooper G; Elliott T; Werner JM; James E
J Biol Chem; 2018 May; 293(20):7538-7548. PubMed ID: 29599287
[TBL] [Abstract][Full Text] [Related]
4. A systematic re-examination of processing of MHCI-bound antigenic peptide precursors by endoplasmic reticulum aminopeptidase 1.
Mavridis G; Arya R; Domnick A; Zoidakis J; Makridakis M; Vlahou A; Mpakali A; Lelis A; Georgiadis D; Tampé R; Papakyriakou A; Stern LJ; Stratikos E
J Biol Chem; 2020 May; 295(21):7193-7210. PubMed ID: 32184355
[TBL] [Abstract][Full Text] [Related]
5. Trimming of MHC Class I Ligands by ERAP Aminopeptidases.
Weimershaus M; Evnouchidou I; Li L; van Endert P; Bouvier M
Methods Mol Biol; 2019; 1988():31-43. PubMed ID: 31147930
[TBL] [Abstract][Full Text] [Related]
6. The ERAP1 active site cannot productively access the N-terminus of antigenic peptide precursors stably bound onto MHC class I.
Mavridis G; Mpakali A; Zoidakis J; Makridakis M; Vlahou A; Kaloumenou E; Ziotopoulou A; Georgiadis D; Papakyriakou A; Stratikos E
Sci Rep; 2021 Aug; 11(1):16475. PubMed ID: 34389743
[TBL] [Abstract][Full Text] [Related]
7. ERAP1 shapes just part of the immunopeptidome.
Admon A
Hum Immunol; 2019 May; 80(5):296-301. PubMed ID: 30849449
[TBL] [Abstract][Full Text] [Related]
8. Editing the immunopeptidome of melanoma cells using a potent inhibitor of endoplasmic reticulum aminopeptidase 1 (ERAP1).
Koumantou D; Barnea E; Martin-Esteban A; Maben Z; Papakyriakou A; Mpakali A; Kokkala P; Pratsinis H; Georgiadis D; Stern LJ; Admon A; Stratikos E
Cancer Immunol Immunother; 2019 Aug; 68(8):1245-1261. PubMed ID: 31222486
[TBL] [Abstract][Full Text] [Related]
9. Peptide Trimming for MHC Class I Presentation by Endoplasmic Reticulum Aminopeptidases.
Compagnone M; Fruci D
Methods Mol Biol; 2019; 1988():45-57. PubMed ID: 31147931
[TBL] [Abstract][Full Text] [Related]
10. The ER Aminopeptidases, ERAP1 and ERAP2, synergize to self-modulate their respective activities.
Martín-Esteban A; Rodriguez JC; Peske D; Lopez de Castro JA; Shastri N; Sadegh-Nasseri S
Front Immunol; 2022; 13():1066483. PubMed ID: 36569828
[TBL] [Abstract][Full Text] [Related]
11. An Overview on ERAP Roles in Infectious Diseases.
Saulle I; Vicentini C; Clerici M; Biasin M
Cells; 2020 Mar; 9(3):. PubMed ID: 32183384
[TBL] [Abstract][Full Text] [Related]
12. Identification of an Unconventional Subpeptidome Bound to the Behçet's Disease-associated HLA-B*51:01 that is Regulated by Endoplasmic Reticulum Aminopeptidase 1 (ERAP1).
Chen L; Shi H; Koftori D; Sekine T; Nicastri A; Ternette N; Bowness P
Mol Cell Proteomics; 2020 May; 19(5):871-883. PubMed ID: 32161166
[TBL] [Abstract][Full Text] [Related]
13. Regulation of ERAP1 and ERAP2 genes and their disfunction in human cancer.
Compagnone M; Cifaldi L; Fruci D
Hum Immunol; 2019 May; 80(5):318-324. PubMed ID: 30825518
[TBL] [Abstract][Full Text] [Related]
14. Crystal structure of a polypeptide's C-terminus in complex with the regulatory domain of ER aminopeptidase 1.
Sui L; Gandhi A; Guo HC
Mol Immunol; 2016 Dec; 80():41-49. PubMed ID: 27825049
[TBL] [Abstract][Full Text] [Related]
15. The ER aminopeptidase, ERAP1, trims precursors to lengths of MHC class I peptides by a "molecular ruler" mechanism.
Chang SC; Momburg F; Bhutani N; Goldberg AL
Proc Natl Acad Sci U S A; 2005 Nov; 102(47):17107-12. PubMed ID: 16286653
[TBL] [Abstract][Full Text] [Related]
16. Influence of ERAP1 and ERAP2 gene polymorphisms on disease susceptibility in different populations.
Yao Y; Liu N; Zhou Z; Shi L
Hum Immunol; 2019 May; 80(5):325-334. PubMed ID: 30797823
[TBL] [Abstract][Full Text] [Related]
17. Separate effects of the ankylosing spondylitis associated ERAP1 and ERAP2 aminopeptidases determine the influence of their combined phenotype on the HLA-B*27 peptidome.
Martín-Esteban A; Sanz-Bravo A; Guasp P; Barnea E; Admon A; López de Castro JA
J Autoimmun; 2017 May; 79():28-38. PubMed ID: 28063628
[TBL] [Abstract][Full Text] [Related]
18. ERAP, KIR, and HLA-C Profile in Recurrent Implantation Failure.
Piekarska K; Radwan P; Tarnowska A; Wiśniewski A; Radwan M; Wilczyński JR; Malinowski A; Nowak I
Front Immunol; 2021; 12():755624. PubMed ID: 34745129
[TBL] [Abstract][Full Text] [Related]
19. Endoplasmic reticulum aminopeptidase 1 (ERAP1) trims MHC class I-presented peptides in vivo and plays an important role in immunodominance.
York IA; Brehm MA; Zendzian S; Towne CF; Rock KL
Proc Natl Acad Sci U S A; 2006 Jun; 103(24):9202-7. PubMed ID: 16754858
[TBL] [Abstract][Full Text] [Related]
20. The Impact of the 'Mis-Peptidome' on HLA Class I-Mediated Diseases: Contribution of ERAP1 and ERAP2 and Effects on the Immune Response.
Tedeschi V; Paldino G; Paladini F; Mattorre B; Tuosto L; Sorrentino R; Fiorillo MT
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33348540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
